An estimated 1.4 billion people globally carry elevated lipoprotein(a), a genetically inherited cardiovascular risk factor that statins do not lower. Inside the biology of Lp(a), why the science went quiet…
Lp(a) affects one in five adults worldwide yet has had no targeted therapy for sixty years. In 2026, four Phase 3 trials including HORIZON, OCEAN(a)-Outcomes, ACCLAIM-Lp(a), and a new oral…
After two decades of waiting, polygenic risk scores and pharmacogenomic testing are moving from research tools into real clinical practice. From the Broad Institute’s multi ancestry GPSMult score to the…
For decades, cardiac amyloidosis was a diagnosis cardiologists whispered and patients rarely heard. In 2026, tafamidis, acoramidis, RNA silencers, and a CRISPR gene editing therapy are transforming ATTR care and…
Phase 3 trials of pelacarsen, olpasiran, lepodisiran, and the first oral Lp(a) drug muvalaplin are ending cardiology’s sixty year blind spot on lipoprotein(a), a genetically determined particle that silently elevates…
A cluster of landmark studies is forcing scientists to ask a radical question: could the drugs that conquered obesity also slow the biological clock? The answer is more complicated, and…
Roughly one in five adults worldwide carries a genetic condition that roughly doubles their lifetime cardiovascular risk. Lipoprotein(a) is invisible to standard cholesterol panels, cannot be lowered by diet or…
A wrist worn bracelet that measures blood pressure continuously throughout the day and night using optical sensors, CE marked in Europe and awaiting FDA clearance in the United States. The…
The first FDA cleared cuffless blood pressure monitor designed for clinical and remote patient monitoring, using a chest worn patch to continuously track blood pressure, heart rate, respiratory rate, and…
The most advanced digital stethoscope available, combining AI powered heart sound analysis with a single lead ECG to screen for murmurs, AFib, and structural heart disease simultaneously during routine examination….
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.